Cargando…
Prognostic factors for tumor recurrence in endometrioid endometrial cancer stages IA and IB
Risk grouping for treatment and follow-up strategy of early stage endometrial cancer is confusing to apply in clinical conditions. We investigated the stage-based prognostic factors for tumor recurrence in stage I endometrial cancer with endometrioid histology (EEC). The medical records of women dia...
Autores principales: | Han, Kyung Hee, Kim, Hee Seung, Lee, Maria, Chung, Hyun Hoon, Song, Yong Sang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Wolters Kluwer Health
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5457879/ https://www.ncbi.nlm.nih.gov/pubmed/28538399 http://dx.doi.org/10.1097/MD.0000000000006976 |
Ejemplares similares
-
Effect of neoadjuvant chemotherapy on platinum resistance in stage IIIC and IV epithelial ovarian cancer
por: Luo, Yanlin, et al.
Publicado: (2016) -
A novel epithelial–mesenchymal transition-related lncRNA signature predicts prognosis and immune status in endometrioid endometrial cancer
por: Jin, Yichao, et al.
Publicado: (2023) -
The Prognostic Value of Retroperitoneal Lymphadenectomy in Apparent Stage IA Endometrial Endometrioid Cancer
por: Liu, Zhao, et al.
Publicado: (2021) -
Stratification of risk groups according to survival after recurrence in endometrial cancer patients
por: Shim, Seung-Hyuk, et al.
Publicado: (2017) -
Outcomes of Patients With Surgically and Pathologically Staged IIIA-IVB Pure Endometrioid-type Endometrial Cancer: A Taiwanese Gynecology Oncology Group (TGOG–2005) Retrospective Cohort Study (A STROBE-Compliant Article)
por: Chen, Jen-Ruei, et al.
Publicado: (2016)